Stephen Pandol

Dr. Stephen Pandol is a prominent researcher and the director of Basic and Translational Research at Cedars-Sinai, specializing in the relationship between metabolic diseases and cancer. He has been instrumental in highlighting the strong link between type 2 diabetes and pancreatic cancer, emphasizing that metabolic disease is an independent risk factor for various cancers. His research focuses on identifying potential biomarkers that could help in the early detection of pancreatic cancer, which is crucial given its aggressive nature and poor prognosis.